Endotronics Inc said because of itsdecisions to discontinue development of health care products,reorganize under Chapter 11 and establish adequate allowancesfor uncollectible receivables, it expects to establish reservestotaling about 11 mln dlrs in the March 31 second quarter.    The company said it plans to seek buyers for health caretechnologies including proprietary rights to a Hepatitis BVaccine and technologies related to LAK cell cancerimmunotherapy. Reuter&#3;